Literature DB >> 26450478

Proton Pump Inhibitor-Associated C. difficile Infection in a Peritoneal Dialysis Patient.

Susan L Ziolkowski1, Michelle H Malabanan2, Scott E Liebman2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26450478      PMCID： PMC4597992          DOI： 10.3747/pdi.2014.00057

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN： 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  16 in total

1.  Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.

Authors:  Chun Shing Kwok; Aaron Kobina Arthur; Chukwudubem Ifeanyichukwu Anibueze; Sonal Singh; Rodrigo Cavallazzi; Yoon Kong Loke
Journal:  Am J Gastroenterol       Date:  2012-04-24       Impact factor: 10.864

Review 2.  Characteristics and causes of immune dysfunction related to uremia and dialysis.

Authors:  Aline Borsato Hauser; Andréa E M Stinghen; Sawako Kato; Sérgio Bucharles; Carlos Aita; Yukio Yuzawa; Roberto Pecoits-Filho
Journal:  Perit Dial Int       Date:  2008-06       Impact factor: 1.756

Review 3.  ISPD position statement on reducing the risks of peritoneal dialysis-related infections.

Authors:  Beth Piraino; Judith Bernardini; Edwina Brown; Ana Figueiredo; David W Johnson; Wai-Choong Lye; Valerie Price; Santhanam Ramalakshmi; Cheuk-Chun Szeto
Journal:  Perit Dial Int       Date:  2011-08-31       Impact factor: 1.756

4.  Glucose-based peritoneal dialysis fluids downregulate toll-like receptors and trigger hyporesponsiveness to pathogen-associated molecular patterns in human peritoneal mesothelial cells.

Authors:  Jun Wu; Xiao Yang; Yun-Fang Zhang; Ya-Ning Wang; Mei Liu; Xiu-Qing Dong; Jin-Jin Fan; Xue-Qing Yu
Journal:  Clin Vaccine Immunol       Date:  2010-03-03

Review 5.  Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection.

Authors:  C Bavishi; H L Dupont
Journal:  Aliment Pharmacol Ther       Date:  2011-10-17       Impact factor: 8.171

6.  Impairment of innate cellular response to in vitro stimuli in patients on continuous ambulatory peritoneal dialysis.

Authors:  Minoru Ando; Asuka Shibuya; Masako Yasuda; Naoko Azuma; Ken Tsuchiya; Takashi Akiba; Kousaku Nitta
Journal:  Nephrol Dial Transplant       Date:  2005-08-02       Impact factor: 5.992

7.  Impact of dialysis on gastroesophageal reflux, dyspepsia, and proton pump inhibitor treatment in patients with chronic renal failure.

Authors:  Hans Strid; Andreas Fjell; Magnus Simrén; Einar S Björnsson
Journal:  Eur J Gastroenterol Hepatol       Date:  2009-02       Impact factor: 2.566

8.  Gastric acid suppression and the risk of enteric peritonitis in peritoneal dialysis patients.

Authors:  Sharon J Nessim; George Tomlinson; Joanne M Bargman; Sarbjit Vanita Jassal
Journal:  Perit Dial Int       Date:  2008 May-Jun       Impact factor: 1.756

9.  Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.

Authors:  Amit S Chitnis; Stacy M Holzbauer; Ruth M Belflower; Lisa G Winston; Wendy M Bamberg; Carol Lyons; Monica M Farley; Ghinwa K Dumyati; Lucy E Wilson; Zintars G Beldavs; John R Dunn; L Hannah Gould; Duncan R MacCannell; Dale N Gerding; L Clifford McDonald; Fernanda C Lessa
Journal:  JAMA Intern Med       Date:  2013-07-22       Impact factor: 21.873

10.  Clinical risk factors for severe Clostridium difficile-associated disease.

Authors:  Timothy J Henrich; Douglas Krakower; Asaf Bitton; Deborah S Yokoe
Journal:  Emerg Infect Dis       Date:  2009-03       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.